Beta2 Glycoprotein1 Antibodies IgM
Beta-2 glycoprotein 1 IgM antibodies are autoantibodies associated with inappropriate blood clotting. Beta-2 glycoprotein antibodies are antiphospholipid antibodies that mistakenly target the body's own lipid-proteins found in cell membranes and platelets. The presence of antiphospholipid antibodies interfere with the body's blood clotting process and increases a person's risk of developing inappropriate blood clots. primary antibodies that are released into the blood early in the immune response
IgM antibodies are primary antibodies released into the blood early in the immune response. Antiphospholipid antibodies are most frequently seen in people with the autoimmune disorder antiphospholipid syndrome (APS), which is associated with frequent blood clots, a low platelet count or with pregnancy complications such as pre-eclampsia and recurrent miscarriages.
What might a high result mean?
The presence of beta 2 glycoprotein IgM antibodies increases the autoimmune thrombosis risk and may increase the risk of miscarriage caused by thrombosis.